Navigation Links
Study to identify best rehabilitation therapies for patients with traumatic brain injuries
Date:12/15/2008

CHICAGO Rush University Medical Center and 10 other healthcare facilities in the U.S. and Canada have been awarded a $4.3 million grant from the National Institutes of Health to identify which rehabilitation therapies, or combination of therapies, can best help victims of traumatic brain injuries. Rush is the only center in Illinois participating in the study.

"Our aim in this study is to isolate individual components of the range of therapies we use to treat our patients and determine how, and to what degree, each is associated with improved function," said Dr. James Young, chairman of the department of physical medicine and rehabilitation at Rush and an internationally recognized expert in the treatment of brain injuries.

The five-year study will collect the records of more than 2,300 patients who have suffered moderate to severe traumatic brain injuries, including detailed demographic, diagnostic and clinical profiles of each patient. Daily logs will be kept of the individually tailored treatment programs the patients undergo in physical therapy, occupational therapy, speech/language therapy, physiatry (physical medicine), psychology/psychiatry, and social support. Outcomes will be catalogued and correlated with both the patients' characteristics and therapeutic interventions.

The researchers will then analyze the data to determine which therapies were the most successful in improving outcomes for patients with different types and severities of traumatic brain injuries.

Patients will also be followed for a full year after being discharged to assess their quality of life, including whether they were able to live independently, drive a vehicle, and participate in daily activities.

The analysis will involve an unusual research methodology called practice-based evidence for clinical practice improvement, which relies on data from routine clinical practice to determine what works for whom, when, and at what cost. The methodology has been used successfully to improve treatment for stroke.

Traumatic brain injury occurs when the head suddenly and violently hits an object, as in a fall or car crash, or when an object, such as a bullet, pierces the skull and enters brain tissue. Symptoms of a traumatic brain injury can be mild, moderate, or severe, and vary depending on the extent and location of the brain damage. For patients with moderate or severe injuries, symptoms range from headaches and lethargy to convulsions, loss of coordination, confusion, cognitive deficits, and behavior and mood changes.

Research to date has done little to help identify the best treatments for the range of symptoms. Randomized clinical trials of rehabilitation therapies, for example, typically evaluate only specific treatments for a select group of patients. Results are not general enough to apply to the whole population of traumatic brain injury patients.

By isolating individual components of therapy as applied to patients with different degrees of traumatic brain injuries, the researchers expect to be able to prescribe best practices for rehabilitation, raising the standard of treatment in facilities all across the country.

"From the extraordinary wealth of data we'll collect in this five-year analysis, we will be able to offer clinicians the information that can help them evaluate their current treatment practices and select therapies that are most likely to help their patients," Young said. "This is medicine at its best: treatment based on the results of years of clinical practice."


'/>"/>

Contact: Sharon Butler
sharon_butler@rush.edu
312-942-7816
Rush University Medical Center
Source:Eurekalert

Related medicine news :

1. Double Blind Study Proves The Pink Patch Works for Weight Loss
2. First Patient from CyberKnife Center of Palm Beach Enrolled in Worldwide Landmark Study of Operable Lung Cancer Patients
3. Planned safety analysis of a breast cancer prevention study reveals encouraging news for Exemestane
4. Genomic Health Announces Study Establishing the Utility of Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated with Aromatase Inhibitors
5. Wyeth Announces Positive Data from Phase 2 Study of Neratinib in Advanced HER-2-Positive Breast Cancer
6. Partnership for a Drug-Free America(R) Responds to 2008 Monitoring the Future Study Results
7. UB driver simulation study targets high-risk teenage drivers
8. Employer Vantage From HealthLeaders-InterStudy Provides a Snapshot of Both Self- and Fully-Insured Health Benefits to Help Pharmaceutical and Diagnostic Manufacturers Identify Business Opportunities
9. Study shows major pain research funding decline at NIH
10. Womens magazines downplay emotional health risks of cosmetic surgery: UBC study
11. Study Asks: Are Physicians Overusing an Invasive Cardiac Treatment?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... May 06, 2016 , ... Featured cast and ... unique keynote address at the 2016 Learning Summit , June 12-15, in ... college students. Their stories—of complicated family issues, financial difficulties, and other personal obstacles—are ...
(Date:5/6/2016)... ... May 06, 2016 , ... ... reduce fat areas around the body, is the most popular among body sculpting ... released make perfect sense to cosmetic surgeon Dr. Richard Buckley, medical director of ...
(Date:5/6/2016)... ... May 06, 2016 , ... Canadian author Mark Black is a speaker, author, and ... Heart" around the world … with the help of his publisher Strategic Book Group and ... lay in a hospital bed waiting for a miracle: He needed a heart and double-lung ...
(Date:5/6/2016)... ... May 06, 2016 , ... Few ... which made headlines mostly for its cost despite its potential to wipe out ... surrounding the drug—part of a class called direct-acting antivirals (DAAs)—have created fallout in ...
(Date:5/6/2016)... ... 2016 , ... RowdMap, Inc. co-founder, Joshua Rosenthal, PhD, joins ... Deputy Administrator at Centers for Medicare and Medicaid Services (CMS); Ali Khan, MD, ... Officer at Health Care Service Corporation (Blue Cross and Blue Shield of Illinois, ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... ALBANY, New York , May 4, 2016 /PRNewswire/ ... published by Transparency Market Research entitled "Brain Computer Interface Market ... Forecast 2016 - 2024," the  global brain computer interface (BCI) ... bn by 2024. The market is estimated to expand ... period from 2016 to 2024. A BCI ...
(Date:5/4/2016)... -- Yissum Research Development Company of ... it had signed an exclusive world-wide licensing and research ... protein degradation and immunomodulatory drugs for cancer and immune ... representing first-in-class therapy for hematologic and solid malignancies. Financial ... The novel technology was developed by Yinon Ben-Neriah ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Acute Ischemic Stroke Market ... to their offering.       (Logo: ... Global Acute Ischemic Stroke Market and Competitive ... Acute Ischemic Stroke pipeline products, Acute Ischemic ...
Breaking Medicine Technology: